The global human growth hormone (HGH) market is a significant and rapidly expanding sector of the pharmaceutical industry. Valued at over USD 6.3 billion, the market is projected to reach over USD 14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of over 12%. This robust growth is driven by the rising prevalence of growth hormone deficiencies and an increasing number of related disorders in both children and adults. The market's expansion is also fueled by advancements in recombinant DNA technology, which has made HGH more widely available. https://www.marketresearchfutu....re.com/reports/human